Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
[French ccAFU guidelines - update 2020-2022: prostate cancer].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
[French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
[French ccAFU guidelines - Update 2018-2020: Prostate cancer].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2019
RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate French ccAFU guidelines – Update 2018–2020: Prostate cancer
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2018
[Immunotherapy in lung cancer: New concepts].
Revue des maladies respiratoires·2018
Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study.
European journal of cancer (Oxford, England : 1990)·2026
Reflections on adjuvant pembrolizumab for triple-negative breast cancer treated with the KEYNOTE-522 regimen: Is it really necessary?
European journal of cancer (Oxford, England : 1990)·2026
The UK's radiotherapy workforce shortage: Reforming regulation to address the gap.
European journal of cancer (Oxford, England : 1990)·2026
A phase I, first-in-human dose-escalation and triple-negative breast cancer dose-expansion study of a TROP2-ADC F0024 (FDA018).
European journal of cancer (Oxford, England : 1990)·2026
Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey.
European journal of cancer (Oxford, England : 1990)·2026
Tumour-first DNA testing as a gateway to germline screening in patients with metastatic prostate cancer.
European journal of cancer (Oxford, England : 1990)·2026
Bone Anabolic Treatment in Patients With Chronic Kidney Disease: A Systematic Review.
Basic & clinical pharmacology & toxicology·2026
Xiaoaiping Injection Combined with Chemotherapy Versus Chemotherapy Alone for Breast Cancer: A Systematic Review and Meta-Analysis.
Journal of visualized experiments : JoVE·2026
Add-on Moxibustion and Detoxification Enema Alleviates Symptoms and Improves Renal Function in Chronic Kidney Disease: A Retrospective Cohort Study.
Journal of visualized experiments : JoVE·2026
Clinical Outcomes of Endoscopic Submucosal Dissection and Transoral Videolaryngoscopic Surgery for Superficial Hypopharyngeal Cancers.
Journal of gastroenterology and hepatology·2026